Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Weinberg

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonistShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligandsQingmei Hong, Raman K Bakshi, James Dellureficio, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2005
Discovery and activity of (1R,4S,6R)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-2-methyl-2-azabicyclo[2.2.2]octane-6-carboxamide (3, RY764), a potent and selective melanocortin subtype-4 receptor agonistZhixiong Ye, Liangqin Guo, Khaled J Barakat, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2002
A role for the melanocortin 4 receptor in sexual functionLex H T Van der Ploeg, William J Martin, Andrew D Howard, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonistShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligandsQingmei Hong, Raman K Bakshi, James Dellureficio, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2005
Discovery and activity of (1R,4S,6R)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-2-methyl-2-azabicyclo[2.2.2]octane-6-carboxamide (3, RY764), a potent and selective melanocortin subtype-4 receptor agonistZhixiong Ye, Liangqin Guo, Khaled J Barakat, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2002
A role for the melanocortin 4 receptor in sexual functionLex H T Van der Ploeg, William J Martin, Andrew D Howard, et al.
Pageof 4